Spondyloarthropathies News

Sex and gender differences between patients with psoriatic arthritis and axial spondyloarthritis may explain why women experience longer diagnostic delays, higher burden and lower drug survival in these diseases, noted a speaker here.

Providers should avoid monotherapy when treating hidradenitis suppurativa, and instead use a “layered and rotated” approach that also addresses the isolating psychosocial aspects of the disease, noted a speaker here.

Primary care providers reported a lack of familiarity with axial spondyloarthritis features, contributing to fewer rheumatology referrals and a delay in diagnosis, noted a presenter at the 2021 North American Young Rheumatology Investigator Forum.

Dermatologists should be prepared to discuss COVID-19 vaccines with their patients who have immune-mediated inflammatory diseases and how biologic treatments may be affected, according to a review.

Shared features and clinical presentations can make diagnosis and management of psoriatic arthritis, non-radiographic axial spondyloarthritis and reactive arthritis particularly challenging, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.

Partnerships between rheumatologists and specially trained advanced practice providers in primary care can reduce diagnostic delay and shorten wait times in axial spondyloarthritis, according to data published in Arthritis Care & Research.

Approximately 18% of patients in a rheumatic disease registry used cannabis in 2019, up from 6.3% in 2014, with the highest prevalence occurring in states where its use is legal, according to data published in Arthritis Care & Research.

This past spring, two studies shed light on how some of the largest clinician organizations and publishers in rheumatology, including the American College of Rheumatology and EULAR, have failed to provide adequate training materials or clear guidelines when it comes to caring for patients of color.

Upadacitinib 15 mg demonstrates consistent, sustained efficacy in ankylosing spondylitis through year 1, according to data published in Arthritis & Rheumatology.

As the standard of care has shifted away from routine opioids for back pain, physicians with higher American Board of Internal Medicine exam scores have been less likely to prescribe opioids than those with lower scores, according to data.